Jaime Landman

Jaime Landman, M.D., is Professor and Chair of the Department of Urology at the University of California, Irvine School of Medicine. He also holds the Endowed Chair in Urological Surgical Oncology and leads one of the most innovative urology departments in the country. Dr. Landman previously served as Director of Minimally Invasive Urology at Columbia University College of Physicians and Surgeons before joining UC Irvine in 2011.

His clinical and academic leadership focuses on advancing minimally invasive techniques in kidney surgery, with a strong emphasis on patient-centered innovation and education.

• Undergraduate: University of Michigan (Honors College)
• Medical School: Columbia College of Physicians and Surgeons
• Residency: Mt. Sinai School of Medicine
• Fellowship: Washington University Division of Urology

Dr. Landman is an internationally recognized expert in the management of kidney cancer and complex kidney stones. His research focuses on stone disease, tumor markers for urologic cancers, and the relationship between kidney cancer and surrounding tissues. He pioneered the combined antegrade and retrograde approach for complex kidney stones and developed novel diagnostic biopsy techniques and ablation devices now used globally. His work has redefined standards in laparoscopic partial nephrectomy, ureteroscopy, and percutaneous nephrolithotomy.

Though the provided text does not list specific publications, Dr. Landman's body of work consistently centers on surgical innovation, diagnostic precision, and minimally invasive therapies in urology, particularly for renal tumors and stone disease. His contributions reflect a strong trend toward improving patient outcomes through technological advancement and evidence-based technique refinement.

Dr. Landman has received widespread recognition through patient testimonials and professional leadership, though specific scientific awards are not mentioned in the text.

He actively mentors and trains future urologists through his role as department chair and by directing the Small Renal Mass Mini-Fellowship at UCI and the Management of Small Renal Tumors course at the American Urological Association annual meeting. His department has secured clinical and research support to develop new technologies and treatment protocols, although specific grants are not listed.

Dr. Landman directs key clinical and educational programs at UC Irvine, including the UCI Kidney Stone Center, and leads a multidisciplinary team focused on surgical innovation, patient care, and translational research in urologic oncology and stone disease.